-
公开(公告)号:US08563717B2
公开(公告)日:2013-10-22
申请号:US13058465
申请日:2009-08-07
申请人: Helene Bazin-Lee , Diane Mary Coe , Linos Lazarides , Charlotte Jane Mitchell , Stephen Allan Smith , Naimisha Trivedi
发明人: Helene Bazin-Lee , Diane Mary Coe , Linos Lazarides , Charlotte Jane Mitchell , Stephen Allan Smith , Naimisha Trivedi
IPC分类号: A61K31/522 , A61P29/02 , A61P37/08 , C07D473/16
CPC分类号: C07D473/16 , A61K31/522 , C07D473/18
摘要: The present invention relates to compounds of formula (I): wherein R1 is C1-6alkylamino, or C1-6alkoxy; R2 is a group having the structure: n is an integer having a value of 1 to 6; Het is a 6-membered saturated heterocycle containing one nitrogen atom wherein Het is attached to the —(CH2)n— moiety at any carbon atom of the heterocycle; R3 is hydrogen, C1-8alkyl, or C3-7cycloalkylC0-6alkyl; and salts thereof are inducers of human interferon. Compounds which induce human interferon may be useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, the treatment of infectious diseases and cancer, and may also be useful as vaccine adjuvants.
摘要翻译: 本发明涉及式(I)的化合物:其中R 1是C 1-6烷基氨基或C 1-6烷氧基; R2是具有以下结构的基团:n是具有1至6的整数; Het是含有一个氮原子的6元饱和杂环,其中Het与杂环的任何碳原子连接至 - (CH 2)n - 部分; R3是氢,C1-8烷基或C3-7环烷基C0-6烷基; 其盐是人类干扰素的诱导剂。 诱导人类干扰素的化合物可用于治疗各种疾病,例如治疗过敏性疾病和其它炎性病症,例如过敏性鼻炎和哮喘,治疗感染性疾病和癌症,并且也可用作疫苗佐剂。
-
公开(公告)号:US20110144136A1
公开(公告)日:2011-06-16
申请号:US13058465
申请日:2009-08-07
申请人: Helene Bazin-Lee , Diane Mary Coe , Linos Lazarides , Charlotte Jane Mitchell , Stephen Allan Smith , Naimisha Trivedi
发明人: Helene Bazin-Lee , Diane Mary Coe , Linos Lazarides , Charlotte Jane Mitchell , Stephen Allan Smith , Naimisha Trivedi
IPC分类号: A61K31/522 , C07D473/18 , C07D473/16 , A61P29/00 , A61P37/08
CPC分类号: C07D473/16 , A61K31/522 , C07D473/18
摘要: The present invention relates to compounds of formula (I): wherein R1 is C1-6alkylamino, or C1-6alkoxy; R2 is a group having the structure: n is an integer having a value of 1 to 6; Het is a 6-membered saturated heterocycle containing one nitrogen atom wherein Het is attached to the —(CH2)n— moiety at any carbon atom of the heterocycle; R3 is hydrogen, C1-8alkyl, or C3-7cycloalkylC0-6alkyl; and salts thereof are inducers of human interferon. Compounds which induce human interferon may be useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, the treatment of infectious diseases and cancer, and may also be useful as vaccine adjuvants.
摘要翻译: 本发明涉及式(I)的化合物:其中R 1是C 1-6烷基氨基或C 1-6烷氧基; R2是具有以下结构的基团:n是具有1至6的整数; Het是含有一个氮原子的6元饱和杂环,其中Het与杂环的任何碳原子连接至 - (CH 2)n - 部分; R3是氢,C1-8烷基或C3-7环烷基C0-6烷基; 其盐是人类干扰素的诱导剂。 诱导人类干扰素的化合物可用于治疗各种疾病,例如治疗过敏性疾病和其它炎性病症,例如过敏性鼻炎和哮喘,治疗感染性疾病和癌症,并且也可用作疫苗佐剂。
-
公开(公告)号:US20090131458A1
公开(公告)日:2009-05-21
申请号:US12031764
申请日:2008-02-15
IPC分类号: A61K31/522 , C07D473/34 , A61P35/04 , A61P11/06 , A61P37/00
CPC分类号: C07D473/18 , C07D473/16
摘要: The present invention includes novel compounds useful in the treatment of various disorders in particular infectious diseases, cancer, and allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, and as vaccine adjuvants.
摘要翻译: 本发明包括可用于治疗各种疾病,特别是感染性疾病,癌症和过敏性疾病以及其它炎性病症例如过敏性鼻炎和哮喘以及作为疫苗佐剂的新型化合物。
-
公开(公告)号:US20110269781A1
公开(公告)日:2011-11-03
申请号:US13154818
申请日:2011-06-07
IPC分类号: A61K31/522 , A61P37/08
CPC分类号: C07D473/18 , C07D473/16
摘要: The present invention includes novel compounds useful in the treatment of various disorders in particular infectious diseases, cancer, and allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, and as vaccine adjuvants.
摘要翻译: 本发明包括可用于治疗各种疾病,特别是感染性疾病,癌症和过敏性疾病以及其它炎性病症例如过敏性鼻炎和哮喘以及作为疫苗佐剂的新型化合物。
-
公开(公告)号:US20100120799A1
公开(公告)日:2010-05-13
申请号:US12527820
申请日:2008-02-15
IPC分类号: A61K31/522 , C07D473/18 , A61P35/00 , A61P29/00 , A61P11/06
CPC分类号: C07D473/18 , C07D473/16
摘要: Compounds of formula (I): wherein R1 is C1-8alkylamino, C1-8alkoxy, C3-7cycloalkylC1-6alkylamino, C3-7cycloalkylC1-6alkoxy, C1-3alkoxyC2-3alkoxy, or Hetb-C1-3alkoxy; Hetb is a 5- or 6-membered saturated aliphatic heterocycle containing one oxygen atom; R2 is —(CH2)n-Het; n is an integer having a value of 1 to 4; Het is a 5- or 6-membered saturated aliphatic heterocycle containing one oxygen heteroatom, which heterocycle may be substituted by one or two C1-4alkyl groups, and salts and solvates thereof, are inducers of human interferon and may be useful in the treatment of various disorders in particular infectious diseases, cancer, and allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, and as vaccine adjuvants.
摘要翻译: 式(I)化合物:其中R 1是C 1-8烷基氨基,C 1-8烷氧基,C 3-7环烷基C 1-6烷基氨基,C 3-7环烷基C 1-6烷氧基,C 1-3烷氧基C 2-3烷氧基或Hetb-C 1-3烷氧基; Hetb是含有一个氧原子的5或6元饱和脂肪族杂环; R2是 - (CH2)n-Het; n为1〜4的整数, Het是含有一个氧杂原子的5-或6-元饱和脂族杂环,该杂环可以被一个或两个C 1-4烷基取代,其盐和溶剂化物是人类干扰素的诱导剂,可用于治疗 各种疾病,特别是传染病,癌症,过敏性疾病和其他炎性病症,例如过敏性鼻炎和哮喘,以及疫苗佐剂。
-
公开(公告)号:US07977344B2
公开(公告)日:2011-07-12
申请号:US12031764
申请日:2008-02-15
IPC分类号: C07D473/16 , C07D473/18 , A61K31/522 , A61P11/06 , A61P37/08 , C07D307/10 , C07D307/12 , C07D309/04 , C07D309/06 , C07D473/40
CPC分类号: C07D473/18 , C07D473/16
摘要: The present invention includes novel compounds useful in the treatment of various disorders in particular infectious diseases, cancer, and allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, and as vaccine adjuvants.
摘要翻译: 本发明包括可用于治疗各种疾病,特别是感染性疾病,癌症和过敏性疾病以及其它炎性病症例如过敏性鼻炎和哮喘以及作为疫苗佐剂的新型化合物。
-
公开(公告)号:US20140023616A1
公开(公告)日:2014-01-23
申请号:US13942501
申请日:2013-07-15
申请人: Todd Appleby , Hans G. Fliri , Andrew J. Kaets , Linos Lazarides , Richard L. Mackman , Simon N. Pettit , Karine G. Poullennec , Jonathan Sanvoisin , Victoria A. Steadman , Gregory M. Watt
发明人: Todd Appleby , Hans G. Fliri , Andrew J. Kaets , Linos Lazarides , Richard L. Mackman , Simon N. Pettit , Karine G. Poullennec , Jonathan Sanvoisin , Victoria A. Steadman , Gregory M. Watt
CPC分类号: A61K38/06 , A61K45/06 , C07D487/04 , C07D487/08 , C07D498/08 , C07D498/18 , C07K5/02 , C07K5/06052
摘要: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
摘要翻译: 提供式I化合物及其药学上可接受的盐和酯。 所提供的化合物,组合物和方法可用于治疗黄病毒科感染,特别是丙型肝炎感染。
-
公开(公告)号:US20140194345A1
公开(公告)日:2014-07-10
申请号:US14095415
申请日:2013-12-03
申请人: Aaron J. Peoples , Dallas Hughes , Losee Lucy Ling , William Millett , Anthony Nitti , Amy Spoering , Victoria Alexandra Steadman , Jean-Yves Christophe Chiva , Linos Lazarides , Michael Kenyon Jones , Karine Gaelle Poullenec , Kim Lewis
发明人: Aaron J. Peoples , Dallas Hughes , Losee Lucy Ling , William Millett , Anthony Nitti , Amy Spoering , Victoria Alexandra Steadman , Jean-Yves Christophe Chiva , Linos Lazarides , Michael Kenyon Jones , Karine Gaelle Poullenec , Kim Lewis
CPC分类号: C07K7/56 , A61K38/00 , A61K38/15 , C07K11/02 , C12P17/14 , C12P21/02 , C12R1/01 , Y02A50/409 , Y02A50/411 , Y02A50/414 , Y02A50/421 , Y02A50/423 , Y02A50/473 , Y02A50/478 , Y02A50/479 , Y02A50/481 , Y02A50/491
摘要: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
摘要翻译: 本发明一般涉及用于制备这些新型去肽肽的新型脱肽,涉及包含新型脱肽的药物组合物; 以及使用新型depsipeptides来治疗或抑制各种疾病的方法。
-
公开(公告)号:US08513184B2
公开(公告)日:2013-08-20
申请号:US13315069
申请日:2011-12-08
申请人: Todd Appleby , Hans G. Fliri , Andrew J. Keats , Linos Lazarides , Richard L. Mackman , Simon N. Pettit , Karine G. Poullennec , Jonathan Sanvoisin , Victoria A. Steadman , Gregory M. Watt
发明人: Todd Appleby , Hans G. Fliri , Andrew J. Keats , Linos Lazarides , Richard L. Mackman , Simon N. Pettit , Karine G. Poullennec , Jonathan Sanvoisin , Victoria A. Steadman , Gregory M. Watt
CPC分类号: A61K38/06 , A61K45/06 , C07D487/04 , C07D487/08 , C07D498/08 , C07D498/18 , C07K5/02 , C07K5/06052
摘要: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
-
公开(公告)号:US20130022573A1
公开(公告)日:2013-01-24
申请号:US13315069
申请日:2011-12-08
申请人: Todd Appleby , Hans G. Fliri , Andrew J. Keats , Linos Lazarides , Richard L. Mackman , Simon N. Pettit , Karine G. Poullennec , Jonathan Sanvoisin , Victoria A. Steadman , Gregory M. Watt
发明人: Todd Appleby , Hans G. Fliri , Andrew J. Keats , Linos Lazarides , Richard L. Mackman , Simon N. Pettit , Karine G. Poullennec , Jonathan Sanvoisin , Victoria A. Steadman , Gregory M. Watt
CPC分类号: A61K38/06 , A61K45/06 , C07D487/04 , C07D487/08 , C07D498/08 , C07D498/18 , C07K5/02 , C07K5/06052
摘要: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
摘要翻译: 提供式I化合物及其药学上可接受的盐和酯。 所提供的化合物,组合物和方法可用于治疗黄病毒科感染,特别是丙型肝炎感染。
-
-
-
-
-
-
-
-
-